RBOT (Vicarious Surgical Inc.) Stock Analysis - SEC Filings

Vicarious Surgical Inc. (RBOT) is a publicly traded Healthcare sector company. As of May 21, 2026, RBOT trades at $1.92 with a market cap of $13.67M and a P/E ratio of 0.00. RBOT moved -3.52% today. Year to date, RBOT is -80.05%; over the trailing twelve months it is -96.02%. Its 52-week range spans $0.27 to $19.00. Analyst consensus is hold with an average price target of $8.75. Rallies surfaces RBOT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find RBOT SEC filings?

Rallies organizes RBOT SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

RBOT Key Metrics

Key financial metrics for RBOT
MetricValue
Price$1.92
Market Cap$13.67M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$19.00
52-Week Low$0.27
Volume53.79K
Avg Volume0
Revenue (TTM)$0
Net Income$-63.22M
Gross Margin0.00%

Latest RBOT News

Recent RBOT Insider Trades

  • Sachs Adam David sold 942 (~$1.97K) on Feb 20, 2026.
  • Khalifa Sammy sold 754 (~$1.57K) on Feb 20, 2026.
  • Sachs Adam David sold 463 (~$1.37K) on Dec 3, 2025.

RBOT Analyst Consensus

5 analysts cover RBOT: 0 strong buy, 2 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is hold. Average price target: $8.75.

Common questions about RBOT

Where can I find RBOT SEC filings?
Rallies organizes RBOT SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show RBOT 10-K and 10-Q filings?
Rallies organizes RBOT SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is RBOT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for RBOT. It does not provide personalized investment advice.
RBOT

RBOT